文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

经气管切开非机械通气患者应用高流量湿化氧疗的效果观察

[Application of high-flow humidified oxygen therapy in patients with tracheotomy and non-mechanical ventilation].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论气管切开非机械通气成人用THFO可降低下呼吸道感染比例,并促进I、II度黏痰排出,但痰痂形成比例更高。

该研究纳入2019年1月至2020年12月山西省汾阳医院收治的60例气管切开且非机械通气的成人患者,按随机数字表分为文丘里面罩氧疗组与THFO组各30例。观察5天内每日7 AM体温较基线升高1℃、白细胞计数较基线升高2×10⁹/L、氧合指数<300 mmHg、下呼吸道感染(依据影像学)及痰液指数与痰痂形成情况。THFO组体温升高>1℃、WBC升高2×10⁹/L、PaO2/FiO2<300 mmHg及下呼吸道感染比例均显著低于文丘里组(均P<0.05),但痰痂形成与I度黏痰比例显著增高(均P<0.05)。作者认为THFO在气管切开非机械通气期间可维持较高氧分压、理想控制吸入气温湿度,促进I、II度黏痰排出,从而减少下呼吸道感染等气管切开并发症。

要点

  • THFO组下呼吸道感染(依据影像学)比例为6.7%(2/30),低于文丘里组的13.3%(4/30),P<0.05。
  • THFO组氧合指数<300 mmHg比例为3.3%(1/30),低于文丘里组的10.0%(3/30),P<0.05。
  • THFO组体温较基线升高>1℃比例为10.0%(3/30),低于文丘里组的13.3%(4/30),P<0.05。
  • THFO组白细胞较基线升高2×10⁹/L比例为10.0%(3/30),低于文丘里组的30.0%(9/30),P<0.05。
  • THFO组痰痂形成比例为16.7%(5/30)、I度黏痰比例为30.0%(9/30),分别高于文丘里组的6.7%(2/30)与20.0%(6/30),均P<0.05。

适用人群与场景

  • 2019年1月至2020年12月山西省汾阳医院收治的气管切开且非机械通气的成人患者60例,按随机数字表分为文丘里面罩氧疗组与THFO组各30例。

处置流程与药物剂量

  • THFO组给予经气管切开高流量湿化氧疗(THFO)。
  • 文丘里组(不戴面罩)给予文丘里连接MR850底座及呼吸机管路进行氧疗。
  • 观察两组5天内每日7 AM体温较基线升高1℃、白细胞计数较基线升高2×10⁹/L、氧合指数<300 mmHg、下呼吸道感染(依据影像学)及痰液指数与痰痂形成情况。

研究设计与关键结果

  • 随机对照研究,纳入60例气管切开非机械通气成人患者,THFO组与文丘里组各30例;主要观察指标为5天内每日7 AM体温较基线升高1℃、WBC较基线升高2×10⁹/L、PaO2/FiO2<300 mmHg、下呼吸道感染(依据影像学)及痰液指数与痰痂形成。
  • THFO组体温较基线升高>1℃比例10.0%(3/30)vs 文丘里组13.3%(4/30),THFO组降低,P<0.05。
  • THFO组WBC较基线升高2×10⁹/L比例10.0%(3/30)vs 文丘里组30.0%(9/30),THFO组降低,P<0.05。
  • THFO组PaO2/FiO2<300 mmHg比例3.3%(1/30)vs 文丘里组10.0%(3/30),THFO组降低,P<0.05。
  • THFO组下呼吸道感染(依据影像学)比例6.7%(2/30)vs 文丘里组13.3%(4/30),THFO组降低,P<0.05。
  • THFO组痰痂形成比例16.7%(5/30)vs 文丘里组6.7%(2/30),THFO组升高,P<0.05。
  • THFO组I度黏痰比例30.0%(9/30)vs 文丘里组20.0%(6/30),THFO组升高,P<0.05。

证据类型、等级与局限

  • 研究类型:随机对照研究(随机数字表分组),样本量60例,单中心(山西省汾阳医院),人群为气管切开非机械通气成人患者。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,成人气管切开患者在非机械通气期间应用THFO可维持较高氧分压、理想控制吸入气温湿度,促进I、II度黏痰排出,从而减少下呼吸道感染等气管切开并发症。
  • 研究中THFO组痰痂形成比例16.7%(5/30)高于文丘里组的6.7%(2/30),P<0.05,提示应用THFO时需关注痰痂形成。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To observe the effect of tracheotomy high-flow oxygen therapy (THFO) on the clinical efficacy of non-mechanically ventilated patients undergoing a tracheotomy.

METHODS: Sixty adult patients with tracheotomy and non-mechanical ventilation who were diagnosed and treated from January 2019 to December 2020 in Fenyang Hospital of Shanxi Province were enrolled. According to the random number table, the patients were divided into Venturi oxygen therapy group and THFO group, 30 cases in each group. The THFO group was given oxygen therapy with THFO; the Venturi group (without mask) was given Venturi connected the MR850 base and the ventilator tube. Observe the changes of two groups at 7 AM within 5 days, including body temperature which was 1 centigrade higher than the baseline, white blood cell count (WBC) which was 2×109/L higher than baseline, oxygenation index (PaO2/FiO2) < 300 mmHg (1 mmHg = 0.133 kPa), the occurrence of lower respiratory tract infections (based on radiography), and changes in sputum indexing and sputum formation.

RESULTS: Compared with the Venturi oxygen therapy group, the body temperature increased > 1 centigrade, WBC increased by 2×109/L, PaO2/FiO2 < 300 mmHg, and the proportion of lower respiratory tract infection in THFO group decreased significantly [body temperature increased > 1 centigrade: 10.0% (3/30) vs. 13.3% (4/30), WBC increased by 2×109/L: 10.0% (3/30) vs. 30.0% (9/30), PaO2/FiO2 < 300 mmHg: 3.3% (1/30) vs. 10.0% (3/30), the proportion of lower respiratory tract infection: 6.7% (2/30) vs. 13.3% (4/30), all P < 0.05]. The proportion of patients with sputum scab formation and sputum viscosity of I degree were significantly increased [sputum scab formation: 16.7% (5/30) vs. 6.7% (2/30), sputum viscosity of I degree: 30.0% (9/30) vs. 20.0% (6/30), both P < 0.05].

CONCLUSIONS: THFO during non-mechanical ventilation of adult patients with tracheotomy can maintain a higher oxygen partial pressure and ideally control the temperature and humidity of the inhaled gas, promote the discharge of sputum with degree I and II viscosity, thereby reducing the tracheotomy complications such as lower respiratory tract infections.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Guo R, Sun Z, Wang Y, et al. [Application of high-flow humidified oxygen therapy in patients with tracheotomy and non-mechanical ventilation]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34839876. doi:10.3760/cma.j.cn121430-20210425-00104

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。